PETS
PetMed Express, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.80
−2.64%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.2x
Market Cap
$39.05M
MomentumView details →
1D Return
−2.64%
YTD Return
−43.28%
RSI (14)
44.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.2x
Market Cap
$39.05M
RSI (14)
44.0
MomentumView details →
1D Return
−2.64%
YTD Return
−43.28%
SummaryUpdated Jun 1, 2026
PetMed Express, Inc. (NASDAQ:PETS) is a pet pharmacy company founded in 1996 and headquartered in Delray Beach, Florida. The company went public in 1999 and operates as one of the leading direct-to-consumer pet medication and health product retailers in the United States. Over its nearly three-decade history, PetMed Express has evolved from a traditional mail-order pharmacy to a multi-channel digital platform serving pet owners nationwide. The company has undergone significant transformation in recent years, including the acquisition and integration of PetCareRx, positioning itself as a comprehensive pet health and wellness provider beyond just prescription medications.
Similar companies
Latest newsMore news →
PETMED reported first-quarter sales of $41 million.22d agoMicrovision, Inc. appointed Christine Chambers as Chief Financial Officer and principal financial and accounting officer, effective August 27, 2026.26d agoPetMeds entered into a definitive agreement for a sale-leaseback of its headquarters and distribution center buildings for $37 million.43d ago